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ABSTRACT Strategies on informed consent process and capacity monitoring for mild demen-
tia research are at developing state. We reflected on our experience and found that the suc-
cessful collection of informed consent and full participation of PwD required the involvement 
of familiar healthcare professionals/care workers/staff at the recruitment and data collection 
stages and this needs to occur in an active support environment.  Time is another important 
factor affecting the success of the study. 
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Background 
Informed consent in research is a process whereby individuals have the opportunity to 
freely determine whether or not to participate in a study; and this decision requires that in-
dividuals receive appropriate explanation, full understanding and the opportunity to ask 
questions before giving consent. The potential participant must be treated as an autono-
mous agent who is considered to be capable and free to decide, and, therefore, the person 
has the capacity to understand, evaluate, and use the information; and thus is choosing 
without external controls or pressures. For people with dementia, the ability to provide in-
formed consent may be an issue when these individuals are experiencing altered abilities in 
communication, memory, language and perception.   
The issues related to informed consent focus on capacity to decide, disclosure of infor-
mation, assessment of understanding and voluntariness. Having the capacity to decide is a 
necessary prerequisite to giving informed consent; whereas disclosure of information, as-
sessment of understanding, and voluntariness are usually considered to be the common 
elements of informed consent. For people with mild dementia - who are deemed to have 
capacity after an evaluation - support, care and time are crucial to help them understand 
and decide to consent to participation (Helstrom et al, 2007; Beattie et al, 2018; Sherratt et 
al., 2007).  
Researchers require approval from ethics committees and/or institutional review board be-
fore their study can commence. The responsibility of the ethics committee/institutional re-
view board is to ensure that individuals’ rights are protected; that individuals demonstrate 
the capacity to consent; the possible risks to participation are identified and minimised; and 
that the consent document is clear, concise, and accurately represents the study. However, 
there is limited guidance to assist ethics committee/IRB in considering the capacity to give 
consent in dementia research. The Declaration of Helsinki (World Medical Association, 2013), 
the EU’s Ethics for Researchers document (European Commission and Human Services, 2009), 
or the England NHS HRA’s Consent and Participant Information Sheet Preparation Guidance 
(HRA, 2018) do not prescribe specific procedures to determine capacity for dementia re-
search.  There are the existing standard procedures for obtaining informed consent, 
grounded in responsibilities and rights (Bjørnby et al, 2004). This set of procedures, how-
ever, is not consistent with research claiming to be person-centred and which values per-
sonhood (Gerritsen et al., 2018; Thorogood et al., 2018).   
The current ethical application procedure emphasises the product - namely the completion 
of a set of documents and adherence to ethical policies that place high value on the tradi-
tional model of autonomy, beneficence and legal rights - rather than the process of informed 
consent to participation. This process consists of how the information is presented; who de-
scribes the study protocol (and how it is described); the psychological state of individuals; 
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and where (what environment) and by whom (companions, relatives) should informed con-
sent be given.  Attending to the process - rather than the product - can influence the deci-
sion-making and increase the likelihood of participation in research. 
Strategies to facilitate the process to obtain informed consent for dementia research have 
been proposed (Dewing, 2008; Erlen, 2010, Murphy et al, 2015). Dewing (2002) provided a 
framework to obtain informed consent for research that is underpinned by a particularist 
approach. This framework considers informed consent as a continuing activity (Figure 1). A 
particularist approach recognises the personhood, identity and value of person with de-
mentia (PwD); and its continuous informed consent monitoring approach  assesses capacity 
throughout the study (because it acknowledges the ‘then’ and ‘now’ self of research partici-
pants). Dewing also emphasises that researchers need the necessary skills to communicate 
with individuals/participants with capacity issues.  
 
 
Figure 1: Five aspects of the process consent method (Dewing, 2002) 
Apart from sharing Dewing’s strategies (training researcher to collect informed consent, reg-
ular monitoring of the consent process), Erlen (2010) also suggests a need to develop qual-
ity informed consent documents written at a literacy level fitting those of the target popula-
tion and with the involvement of users. Murphy and colleagues (2014) reviewed strategies 
within dementia research literature and synthesized the findings to develop the CORTE 
guide. CORTE stands for ‘gaining COnsent, maximizing Responses, Telling the story, and 
1. Background and preparation 
a. clarify permission to access the person with dementia 
b. establish basic biographical knowledge  
of the person with dementia 
c. assess the person’s usual level of wellbeing 
2. Establishing a basis for capacity 
a. establish whether capacity exists or not 
b. if capacity does not exist, the researcher needs  
to establish to what degree the person usually  
consents to activities in day-to-day life 
3. Initial consent 
a. initial consent for the study. Information about the  
study given in a way that will help the person understand 
4. Ongoing consent monitoring 
a. initial consent on every occasion 
5. Feedback and support 
a. feedback to staff on the person’s wellbeing or concerns 
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Ending on a high’, and is used at the data collection stage. The CORTE guideline was used as 
an analytical tool for relevant research reports; to maximize the meaningful involvement of 
PwD; and act as a learning tool between researchers (Murphy et al., 2014).  
In this paper, we will reflect on our experience of obtaining informed consent and capacity 
monitoring in a multicentre study, with the aim of determining the conditions needed for 
full participation in the study. 
The MinD project 
The “MinD – Designing for People with Dementia: designing for mindful self-empowerment 
and social engagement“ – project is a 4-year project, funded by European Union’s Horizon 
2020 research and innovation programme, which began in 2016. The project aims to help 
people with mild dementia engage in social contexts to improve psychosocial wellbeing and 
self-empowerment. The project combines expertise from 17 organisations from 8 countries 
(United Kingdom, The Netherlands, Germany, Luxemburg, Spain, Italy, Australia and Russia), 
including eight universities, one healthcare policy partner, four healthcare partners, and 
four design/ICT partners.  
The project comprises three phases with involvement from persons with dementia (PwD) at 
all phases. Phase 1 involves a qualitative data collection, aiming to identify the most relevant 
areas of need for assistance with regard to activities of daily living, social engagement, deci-
sion-making and subjective wellbeing. The findings of this phase inform Phase 2 – a co-crea-
tion phase formulating the type and development of designs; and, in Phase 3, the designs 
are evaluated with people with dementia. Ethical approval was obtained from institutional 
review boards and regional ethic committees in all the partner countries before the project 
commenced in 2016.  
Phase 1: Qualitative data collection 
Qualitative data were collected using both individual interviews and focus group discussions 
in Germany, Spain and the Netherlands.  In Germany, participants were recruited at the Alz-
heimer’s Gesellschaft, the Department of Old Psychiatry at the St. Hedwig Hospital, Berlin – 
then interviewed at their homes – while focus group discussions (FCGs) were carried out at 
an occupational therapy practice in Dresden. Participants in Spain were recruited and inter-
viewed at the INTRAS’ Memory Clinic in Valladolid - a social and health resource designed to 
offer (on an ambulatory basis) treatments for the prevention of cognitive impairment, evalu-
ation and neuropsychological rehabilitation.  In the Netherlands, participants were recruited 
and interviewed at Zorggroep Sint Maarten – a nursing home care which also provides am-
bulatory services.  
A topic guide was developed based on a priori knowledge from a literature review, and cov-
ered 4 areas: activities of daily living/managing and coping with daily life; social engagement; 
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supporting psychosocial well-being; and potential for use of technological devices (and atti-
tudes towards them). 
Interviews and FCGs were conducted by researchers who had experience working with PwD 
(or received training prior to the interviews). A note-taker was also present. The interviews 
lasted up to 60 minutes on average, while focus group discussions took up to two hours. All 
interviews and FCGs were audio-recorded with consent from the participants.  Design 
probes were used to facilitate and seek meaningful answers from the participants. A total of 
104 people with mild dementia and their care-givers participated in the study.  Data man-
agement was performed using MaxDA and analysed using Thematic Analysis approach. The 
findings were used to inform the development of designs in Phase 2. 
Phase 2 – Deciding and Developing the Designs 
The findings from Phase 1 were shared with healthcare professionals, PwD and/or PPI (Pa-
tient and Public Involvement) groups in the co-design Phase 2. PPI group workshops - to 
identify and develop the design concept - were organised in Berlin (September 2017: carers 
and healthcare professionals), Barcelona (September 2017: carers and healthcare profes-
sionals), and in the UK at the Nottinghamshire Healthcare Trust (October 2017: carers and 
people with various memory issues).  Another co-design workshop was organised with PwD 
in an Alzheimer’s day care group by the Alzheimer’s Society Research Partnership scheme.  
The final design, The Good Life Kit, consists of 3 components, aiming to fulfil the needs of 
PwD as initially identified in Phase 1. 
Phase 3 – Evaluating the Good Life Kit Design 
The evaluation phase started in the Netherlands, Spain and Germany at the beginning of 
2019, with the UK to follow in March 2019. The evaluation questionnaire was developed us-
ing user-friendly language. It covers aspects required to assess user experience of the new 
product. It was piloted with the PPI group in Nottingham, UK, and additional documents 
were produced to aid the delivery of the evaluation – specifically a user-friendly participant 
information sheet and questionnaires adapted to local context (language and presentation). 
Reflection on the process of obtaining informed consent  
and capacity monitoring  
All the four healthcare centres/clinic and universities completed local institutional applica-
tion forms – and received ethics approval as required – at recruitment and data collection 
stages. We followed institutional ethical procedures to collect informed consent; used expe-
rienced researchers (or researchers who had received training) and data collection tools 
that were developed to meet the needs of the target population; and included members of 
staff (with wide experience of working and caring for people with dementia) and caregivers 
during data collection and evaluation of designs.  
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Process to obtain informed consent and monitoring capacity 
Access to PwD determined the approach that we used to recruit participants into the study. 
Researchers based in healthcare provider organisations - such as clinics or care/nursing 
homes - had direct access to recruit PwD into the study; whereas university-based research-
ers did not have direct access, and thus required assistance and collaboration from case 
workers/managers who worked with PwD. Regardless of the recruitment approach, at all 
stages of the study we involved healthcare professionals familiar to PwD to support and 
monitor capacity. 
Germany: 
The clinician/researcher and her team approached all patients with mild dementia who vis-
ited the clinic for treatment. These were PwD who they thought were able to give consent 
and seemed sufficiently active to talk/participate in activities. The procedure used to ensure 
that PwD have the capacity to consent is as follows: 
— Explain the study in short sentences using few words with no time pressure. 
— Focus on the PwD without interruption from accompanying relative. 
— Enquire if the PwD had any questions. 
— Ask the PwD to repeat what was just explained in their own words –  
to test their understanding of the study and activities. 
— Ask the PwD what would happen if they did not give consent.  
This is to ensure that the PwD understands that the choice of participation  
is voluntary and the care they receive will not be affected if they decide  
to stop before completing the study. 
— Emphasise and clearly state that refusal to participate  
would not affect their treatment or further treatment. 
— Allow time (1–2 days) to provide consent. Give out the consent form and ask 
the PwD to think about their willingness to participate. PwD are asked to re-
turn with the consent form – or ask any questions – within 1–2 days.  
Consent was not monitored during the study in Germany. However, before the commence-
ment of the study, the researchers (who are also staff of the clinic) reiterated that participa-
tion is voluntary and that the participants could stop whenever they want to without giving 
any reason. They also repeated that if a PwD stops participation, any information or data 
provided will be destroyed.  On recruitment, many PwD agreed to participate in the study 
because they feel that it is important to the relative/caregiver and/or the treating therapist. 
The patients are mostly accompanied by the caregiver or a close person. 
Spain: 
Researchers who are also healthcare professionals specialising in dementia care at INTRAS 
recruited eligible PwD among those attending the INTRAS Memory Clinic services, and eval-
uated their capacity to consent.  In simple language, researchers explained the study to the 
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PwD and caregivers (relatives, children, spouse), and then handed them the participant in-
formation sheet, an invitation letter, and consent form written to fit PwD’s literacy needs.  
Potential participants also received a newsletter specially produced to inform PwD and car-
ers about past and current work/activities in INTRAS. 
Upon expression of interest, researchers took time to communicate the information with 
participants, and ensured that PwD were able to understand the information and ask ques-
tions. In all the interviews/discussions, we involved the dementia expert/healthcare staff fa-
miliar with the participants, to monitor capacity and voluntary participation. Researchers 
also paid particular attention to participants’ feelings and expectations - and verbal and 
non-verbal language - during the study. 
The Netherlands: 
Case managers who frequented the nursing home, Zorggroep St Maarten, asked residents 
with mild dementia if they would be willing to participate in the study. They identified PwDs 
who expressed an interest and evaluated their capacity for participation.  Case managers 
subsequently organised the meetings between the potential participants and the University 
of Twente’s researchers. Researchers visited the nursing home, explained the study, col-
lected informed consent and conducted the study. Case managers are regular visitors and 
are known to the participants. They were present throughout the study to monitor capacity 
and, being known to the participants, it would be easy for them to identify behavioural 
change or distress during the study. Participants understood that participation was volun-
tary and they could stop at any time, without their rights and care being affected. One par-
ticipant left the study after consenting, because she did not feel like talking about herself or 
did not like using the Good Life Kit. 
United Kingdom: 
The UK researchers (from the University of Wolverhampton and Manchester Metropolitan 
University) were granted permission by the Alzheimer’s society to run the evaluation of the 
Good Life Kit (This is Me) design with the dementia day group based in Solihull, West Mid-
lands. PwD attending the weekly day group were informed about the study by their care 
manager and worker. They were also handed information about the study and a consent 
form and were told to discuss the study with their carers at home. PwD were given a week 
to decide on participation and to return to the day group on the following week for the 
study. On the day of the evaluation, care workers assessed the capacity of the PwD who 
came to the meeting, and only those who were willing to participate were included.  Before 
informed consent was sought, the researchers explained the study and handed out addi-
tional information about the study.  The participants were divided into 3 groups with 4 in 
each group.  The researcher further explained the study and went through each of the 
items in the consent form. All except two PwD consented to participation; two PwD worried 
about disclosing their names and signatures because they said that their spouses told them 
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strictly not to provide name or sign any document. During the evaluation, capacity was mon-
itored at all time by three care workers who constantly observed participants’ behaviour to 
assess their willingness to continue with the activity. Participants understood that their par-
ticipation was voluntary and they could stop at any time. 
Challenges faced to obtain informed consent and capacity monitoring 
We encountered similar challenges across the four study sites: 
— Using appropriate way of communicating/describing the study with short sen-
tences, yet precise enough to make the aim of the study and questionnaires 
understandable to PwD.  
— Finding the appropriate pace while explaining the study and to not overwhelm 
PwD with information. Studies with PwD therefore cannot be rushed and suffi-
cient time needs to be included to complete the study satisfactorily. 
— Being attentive and showing understanding at all time; as well as being ob-
servant about verbal and non-verbal language which might indicate capacity 
issues and diminished interest in participation. 
— Observing the interaction between caregiver and PwD to make sure that the 
PwD is not pressurised to participate by their caregiver. However, the pres-
ence of caregiver could be positive because PwD felt safe to consent and this 
encouraged their contribution. 
— Needing time to gain trust for PwD to provide personal data such as name 
(first name only was requested) and signature; and to ensure participation.  
PwD were wary when asked to provide personal information, as they had been 
told not to disclose this information by their carer givers and care workers.  In 
future, consideration may be given to involving caregivers in order to secure 
participation of PwD. Also, in order to gain trust, a longer period of time might 
be needed for researchers to familiarise themselves with participants before 
the study. 
— Recognising the many logistical aspects key to ensuring participation and long-
term motivation to stay with the 3-year project; e.g. when and where to meet 
being determined by the participants. 
— Realizing the standard institutional consent form has overly long sentences 
and technical terms which were hard for PwD to read and understand; simple 
and short sentences and font size appropriate to PwD should be used in fu-
ture.   
Our approach to seek informed consent, and monitoring capacity with sensitivity to needs, 
is grounded in the expertise and knowledge of experienced healthcare staff working with 
PwD. The same approach was recommended by Dewing (2002).  Healthcare teams sought 
access to PwD and collected the relevant information about their condition and wellbeing in 
order to assess capacity for recruitment. Potential participants were handed a Participant 
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Information Sheet – consisting of the usual topics: i.e. the purpose of the research; who is 
involved; how to participate; potential risk and harm; voluntary participation; withdrawal and 
standard of care; data management and confidentiality; and contact details of researchers 
and complaint contact details. PwD were allowed time to consider participation. Care was 
taken to present the information, both in simple written and oral formats. The speech was 
adapted in order to ensure PwD were able to clearly understand the information provided 
in the PIS. We took time and care to explain the study and participation, and provided PwD 
with ample time and opportunity to ask questions. Research activities took place in environ-
ments familiar to the PwD – either in the care organizations facilities or the PwD’s home. 
During all research activities involving PwD, case managers/workers known to the PwD ac-
companied university researchers, and were present to assess capacity and monitor behav-
iour.  
In our interactions with PwD, we showed consideration, sensitivity and sensibility, support 
and care. We continued to assess capacity and wellbeing throughout the study with the 
presence of healthcare staff familiar to the participants. We also ensured that we raised 
awareness among ourselves and the participants of their needs and comfort - with the aim 
of establishing an environment for participation that was secure, created a feeling of confi-
dence and motivation, and fostered meaningful participation. Our practice in all the institu-
tions showed that we valued ‘personhood’ and placed the needs of our participants first. We 
also created an environment of mutual respect, kindness, and mutual support between the 
research team and participants in all the institutions involved. 
Discussions 
Current ethics procedures are based on traditional moral theory that bridges philosophical 
and legal approaches to informed consent – i. e. grounded in autonomy, and the role and 
responsibility of researchers to minimise harm and risk. These guidelines place priority on 
the legal rights and the product/outcome (informed consent), rather than the processes of 
delivering and obtaining informed consent, and monitoring capacity and voluntary participa-
tion in dementia research. For dementia research with people with mild dementia, our ex-
perience showed that both product and process are essential to protect PwD from harm 
and risk.  
The lack of ethics guidelines for mild dementia research – particularly focusing on the pro-
cess to determine, and monitor capacity and voluntary participation – has created problems 
within partner countries as we have to rely on our experience and knowledge to deliver an 
ethical study; the problem was further compounded by the differences in setting and con-
text between partners. Using experienced healthcare professionals (clinicians and case 
managers/workers) working with PwD, we were able to successfully recruit participants, 
while facing challenges through the journey arising from our differences.  
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It is widely recognised that dementia research demands a particularist approach which val-
ues personhood and a continuous monitoring of the capacity to consent process; and 
which acknowledges altered abilities in communication, memory, language and perception 
of PwD. Our steps are similar to Dewing’s 5-step informed consent framework, and we de-
veloped and implemented quality protocol and data collection tools including interview 
probes with PwD involvement. We were also supported by care workers/staff members at 
all the stages of the study. This strategy ensured that PwD’s autonomy was protected and 
enhanced at all time.   
Additionally, the successful recruitment and completion of our study is due largely to the ac-
tively supported, mindful and friendly environment we created: underpinned by the follow-
ing principles: 
— Place needs of PwD first –  
acknowledging personhood; showing sensitivity to their needs;  
addressing cognitive abilities and functions at different times  
with simple language, using prompts/cue cards/photos and  
carefully constructed statements to communicate. 
— Create autonomy –  
providing PwD with relevant information to make decisions. 
— Enable autonomy –  
providing active support to PwD so that they can  
be encouraged to retain and express their sense of self,  
rather than simply being protected from harm or risk. 
— Preserve dignity and uphold well-being of PwD.  Treating a person in a way 
which maintains and upholds their values as a human being creates dignity. 
— Promote trust and mutual respect between researchers,  
participants and caregivers. 
— Facilitate the diversity within research team through training and  
developing documents to promote understanding and appreciation. 
— Use communication skills appropriate to PwD. 
— Adopt autonomy monitoring by staff/care workers familiar to the PwD. 
Conclusion 
Treating informed consent as a process and adopting a continuous monitoring of capacity 
to consent and participation in dementia research, are two pertinent elements of valuing 
personhood. However, the success of obtaining informed consent and participation from 
PwD in a multi-centre dementia study hinges on the involvement and presence of 
healthcare professionals or care workers/managers whom are familiar to the PwD at both 
recruitment and data collection stages. In addition, the study needs to be conducted in an 
active support environment that places PwD first, where autonomy is created, enabled and 
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maintained; dignity preserved and well-being upheld; and mutual respect promoted. Re-
searchers also need to have the skill to communicate with PwD and allow sufficient time for 
implementation of study. 
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